6533b852fe1ef96bd12ab552
RESEARCH PRODUCT
Snps in Angiogenic Factors As Predictive Markers for Outcome in Patients (P) with Advanced Non-Squamous Nsclc (NS-NSCLC) Treated with Carboplatin, Paclitaxel (CP) and Bevacizumab (BEV). Final Results of Angiomet Spanish Lung Cancer Group Trial
Rosa RosellOscar JuanB. Massuti SuredaJ. De CastroD. Rodriguez AbreuJose-luis Gonzalez-larribaManuel DomineM. Provencio PullaEloisa Jantus-lewintreCarlos Campssubject
Oncologymedicine.medical_specialtyGroup trialPredictive markerBevacizumabbusiness.industryHematologymedicine.diseaseCarboplatin/paclitaxelCarboplatinchemistry.chemical_compoundOncologychemistryPaclitaxelNon squamousInternal medicinemedicineLung cancerbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2015-04-01 | Annals of Oncology |